Skip to main content

The Role of Red Cell Aging in the Diagnosis of Glycolytic Enzyme Defects

  • Chapter
Red Blood Cell Aging

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 307))

Abstract

During the development from stem cell to mature erythrocyte, the human red cell loses several of its metabolic and synthetic capacities. The mature red cell is devoid of DNA and RNA and therefore lacks the possibility of protein synthesis. With respect to metabolism, the disappearance of mitochondria and ribosomes deprives the erythroid cell from obtaining energy through oxydative phosphorylation and from renewed enzyme required in metabolic processes. As a consequence the mature red cell is almost completely dependent upon anaerobic glycolysis as a source of energy supply during its 120 day mean life span. Despite the limited metabolic capacity of the glycolytic pathway in the mature erythrocyte sufficient ATP is available for processes involved in its optimal functioning i.e. keeping the haem iron in the reduced state, synthesis of glutathione, maintaining the electrochemical gradients over the plasma membrane, salvage of purine nucleotides and protection of hemoglobin against methemoglobin formation and oxidative denaturation. In reticulocytes the energy consumption pattern is completely different. First of all the production of ATP is about 100 times higher than in mature erythrocytes, partly by increased glycolytic enzyme activities and further by a still intact oxidative phosphorylation. The increased activities of glycolytic enzymes in young red cell fractions predominantly concern those of hexokinase, pyruvate kinase and glucose-6-phosphate dehydrogenase. The increased enzyme activities are linearly correlated with the reticulocyte counts in these fractions. This finding suggests that the presumed age dependency of these enzymes is mainly related to reticulocyte maturation. In patients with hemolytic anemia the diagnosis of a deficiency of one of these enzymes may be masked by an increased reticulocyte number. On the other hand in patients with severe transfusiondependent hemolytic anemia, the diagnosis of an erythrocyte enzymopathy is often troubled by the presence of relatively large amounts of donor erythrocytes with normal enzyme activities. In this paper we present a few examples, mainly concerning abnormal pyruvate kinase, illustrating the above mentioned problems, in the diagnosis of an enzymopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H. Chr. Benöhr, and H. D. Waller, Metabolism in hemolytic states, Clin. Haematol., 4:45 (1975).

    PubMed  Google Scholar 

  2. G. Rijksen, J.-W. N. Akkerman, A. W. L. van den Wall, D. Pott hofstede, and G. E. J. Staal, Generalized Hexokinase deficiency in the blood cells of a patient with non-spherocytic hemolytic anemia, Blood, 61:12 (1983).

    PubMed  CAS  Google Scholar 

  3. G. E. J. Staal and G. Rijksen, Regulation of pyruvate kinase in normal and pathological conditions, in “Regulation of Carbohydrate metabolism”, R. Beitner, ed., vol. 1:143, CRC Press, Boca Raton (1985).

    Google Scholar 

  4. K. Imamura, K. Taniuchi and T. Tanaka. Multimolecular forms of pyruvate kinase, J. Biochem. 71:1001 (1972).

    Google Scholar 

  5. G. E. J. Staal, G. Rijksen, A. M. C. Vlug, B. Vromen-van den Bos, J.-W. N. Akkerman, G. Gorter, J. Dierick and M. Petermans. Extreme deficiency of L-type pyruvate kinase with moderate clinical expression, Clin. Chim. Acta 118:241 (1982).

    Article  PubMed  CAS  Google Scholar 

  6. J. Marie, M. P. Simon, J. C. Dreyfus and A. Kahn, One gene, but two messenger RNAs encode liver L and red Cell L’ pyruvate kinase subunits, Nature 292:70 (1981).

    Article  PubMed  CAS  Google Scholar 

  7. M. Cognet, Y. C. Lone, S. Vaulont, A. Kahn and J. Marie, Structure of the rat L-type pyruvate kinase gene, J. Mol. Biol. 196:11 (1987).

    Article  PubMed  CAS  Google Scholar 

  8. G. L. Tremp, J. Boquet, A. Kahn and D. Doegelen, Expression of the rat L-type pyruvate kinase gene from its dual erythroid and liver specific promoter in transgene mice, J. Biol. Chem. 264:19904 (1989).

    PubMed  CAS  Google Scholar 

  9. T. Noguchi, H. Inone and T. Tanaka, The M-and M-types isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing, J. Biol. Chem. 261:13807 (1986).

    PubMed  CAS  Google Scholar 

  10. G. Rijksen, A. J. P. Veerman, G.P.M. Schipper-kester and G. E. J. Staal, Diagnosis of pyruvate kinase deficiency in a transfusion dependent patient with severe hemolytic anemia, American J. of Hematology (1990) in press.

    Google Scholar 

  11. C. M. Rennie, S. Thompson, A. C. Parker, A. Maddy, Human erythrocyte fraction in “Percoll” density gradients, Clin. Chim. Acta 98:119 (1979).

    Article  PubMed  CAS  Google Scholar 

  12. H. E. van Erp, P. J. M. Roholl, E.D. Sprengers, C. W. M. van Veelen, G.E. J. Staal, Production and characteriztion of monoclonal antibodies against human L-type pyruvate kinase, Eur. J. Cell Biol. 47:388 (1988).

    PubMed  Google Scholar 

  13. G. E. J. Staal, G. Jansen and D. Roos, Pyruvate kinase and the “High ATP syndrome”, J. Clin.Invest. 74:231 (1984).

    Article  PubMed  CAS  Google Scholar 

  14. G. E. J. Staal, J. F. Koster, H. Hamp, L. Van Milligen-Boersma and C. Veeger, Human erythrocyte pyruvate kinase. Its purification and some properties. Biochim. Biophys. Acta 227:86 (1971).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Plenum Press, New York

About this chapter

Cite this chapter

Staal, G.E.J., Rijksen, G. (1991). The Role of Red Cell Aging in the Diagnosis of Glycolytic Enzyme Defects. In: Magnani, M., De Flora, A. (eds) Red Blood Cell Aging. Advances in Experimental Medicine and Biology, vol 307. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5985-2_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5985-2_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5987-6

  • Online ISBN: 978-1-4684-5985-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics